2024-05-02 07:00 | UU:AXGN | | News Release200 | Axogen, Inc Reports First Quarter 2024 Financial Results |
2024-04-29 16:50 | UU:AXGN | | News Release200 | Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix(TM) |
2024-04-16 07:00 | UU:AXGN | | News Release200 | Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 |
2024-03-05 07:00 | UU:AXGN | | News Release200 | Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results |
2024-02-13 16:30 | UU:AXGN | | News Release200 | Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024 |
2024-02-02 16:15 | UU:AXGN | | News Release200 | Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) |
2024-01-18 17:00 | UU:AXGN | | News Release200 | Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap |
2024-01-04 16:45 | UU:AXGN | | News Release200 | Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 |
2024-01-04 16:40 | UU:AXGN | | News Release200 | Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025 |
2024-01-04 16:35 | UU:AXGN | | News Release200 | Axogen Announces Promotions on Research and Development Team |
2023-12-26 16:15 | UU:AXGN | | News Release200 | Axogen, Inc. Appoints Kathy Weiler to its Board of Directors |
2023-12-06 07:00 | UU:AXGN | | News Release200 | Axogen Announces Transition of Finance Team Leadership |
2023-12-01 17:00 | UU:AXGN | | News Release200 | Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
2023-11-20 07:00 | UU:AXGN | | News Release200 | Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference |
2023-11-07 07:00 | UU:AXGN | | News Release200 | Axogen, Inc. Reports 2023 Third Quarter Financial Results |
2023-10-18 07:00 | UU:AXGN | | News Release200 | Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023 |
2023-09-05 07:00 | UU:AXGN | | News Release200 | Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector ¢ „ ¢ |
2023-08-31 07:00 | UU:AXGN | | News Release200 | Axogen to Participate at Upcoming Investor Conferences |
2023-08-21 07:00 | UU:AXGN | | News Release200 | Axogen, Inc. Begins Processing Avance ‚ ® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio |
2023-08-07 16:01 | UU:AXGN | | News Release200 | Axogen, Inc. Reports 2023 Second Quarter Financial Results |
2023-07-27 07:00 | UU:AXGN | | News Release200 | Axogen to Participate at Canaccord Genuity ¢ € ™s 43rd Annual Growth Conference |
2023-07-26 07:00 | UU:AXGN | | News Release200 | Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023 |
2023-05-24 07:00 | UU:AXGN | | News Release200 | Axogen to Participate at Jefferies Healthcare Conference |
2023-05-12 07:00 | UU:AXGN | | News Release200 | Axogen to Participate at JMP Securities Life Sciences Conference |
2023-05-09 07:00 | UU:AXGN | | News Release200 | Axogen, Inc. Reports 2023 First Quarter Financial Results |